Skip to main content
. Author manuscript; available in PMC: 2023 Jan 5.
Published in final edited form as: Clin Lung Cancer. 2022 Apr 29;23(5):402–409. doi: 10.1016/j.cllc.2022.03.012

Table 6.

Clinical and procedure characteristics stratified by patient population

Characteristic DM (n=248) Non-DM (n=2784) P-Value

Clinical Features
°°Age (mean, SD) 64.76 (5.06) 64.15 (5.11) 0.07
Male 189 (76.2%) 1733 (62.3%) <0.001
BMI (≥30) 98 (39.5%) 485 (17.4%) <0.001
°°Pack Years (mean, SD) 63.52 (32.45) 61.66 (31.24) 0.37
Pack Years (≥30) 223 (89.9%) 2465 (88.5%) 0.51
Smoking Status
 CS 77 (31.0%) 1350 (49.1%) <0.001
 FS 171 (69.0%) 1434 (52.2%)
Comorbidities
 COPD 47 (19.0%) 511 (18.4%) 0.82
 History of Myocardial Infarction 72 (29.0%) 363 (13.0%) <0.001
 Hypertension 146 (58.9%) 901 (32.4%) <0.001
 History of Stroke 13 (5.24%) 96 (3.45%) 0.15
 Liver Disease 7 (2.8%) 129 (4.6%) 0.19
 Any History of Cancer 15 (6.1%) 167 (6.0%) 0.97
 DCCI** 1.43 (0.63) 0.27 (0.52) <0.001
Procedure
 Surgical Biopsy 74 (29.8%) 1025 (36.8%) 0.03
 Bronchoscopy 134 (54.0%) 1545 (55.5%) 0.66
 Needle Biopsy 124 (50.0%) 1417 (50.9) 0.77
 Mediastinoscopy 23 (9.3%) 369 (13.3%) 0.07
 Other Procedure 132 (53.2) 1643 (59.0%) 0.08
  °°Procedure category sum 1.9637 (1.0848) 2.1548 (1.111) 0.01
Complications
 Major 9 (3.6%) 149 (5.4%) 0.24
 Intermediate 23 (9.3%) 547 (19.6%) <0.001
 Minor 7 (2.8%) 137 (4.9%) 0.14
  Any Complication 30 (12.1%) 661 (23.7%) <0.001
 Respiratory 19 (7.7%) 439 (15.8%) 0.001
 Cardiac 7 (2.8%) 162 (5.8%) 0.0487
 Infectious 3 (1.2%) 134 (4.8%) 0.01
**

() Indicates percentage for categorical variables and SD for linear variables.

**

Deyo Charleson Comorbidity Index

°°

Pooled-t test was employed. For all other variables chi-squared test was applied.